会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 52. 发明授权
    • Cardiac analysis system for comparing clinical and induced ventricular tachycardia events
    • 用于比较临床和诱导性室性心动过速事件的心脏分析系统
    • US08634902B2
    • 2014-01-21
    • US12820879
    • 2010-06-22
    • Michael E. BenserGene A. BornzinEuljoon ParkKyungmoo RyuMichael Hardage
    • Michael E. BenserGene A. BornzinEuljoon ParkKyungmoo RyuMichael Hardage
    • A61B5/04
    • A61B5/0422A61B5/0031A61B5/0464A61B18/1492A61N1/3621
    • A cardiac analysis system is provided that includes an implantable medical device (IMD), at least one sensor, and an external device. The IMD has electrodes positioned proximate to a heart that sense first cardiac signals of the heart and associated with a clinical ventricular tachycardia (VT) event and second cardiac signals associated with an induced VT event. The sensor measures first and second cardiac parameters of the heart associated with the clinical and induced VT events, respectively. The external device is configured to receive the first and second cardiac signals associated with the clinical and the induced VT events and the first and second cardiac parameters associated with the clinical and the induced VT events. The external device compares the first and second cardiac signals and compares the first and second cardiac parameters to determine if the clinical and induced VT events are a common type of VT event.
    • 提供了包括可植入医疗装置(IMD),至少一个传感器和外部装置的心脏分析系统。 IMD具有位于心脏附近的电极,其感测心脏的第一心脏信号并与临床心室性心动过速(VT)事件和与诱导的VT事件相关联的第二心脏信号相关联。 该传感器分别测量与临床和诱导VT事件相关的心脏的第一和第二心脏参数。 外部设备被配置为接收与临床和诱导的VT事件相关联的第一和第二心脏信号以及与临床和诱导的VT事件相关联的第一和第二心脏参数。 外部设备比较第一和第二心脏信号,并比较第一和第二心脏参数以确定临床和诱导的VT事件是否是常见类型的VT事件。
    • 53. 发明授权
    • System and method for emulating a surface EKG for use with transtelephonic monitoring of an implantable medical device
    • 用于模拟表面EKG的系统和方法,用于可植入医疗装置的经耳监测
    • US07945314B1
    • 2011-05-17
    • US11432636
    • 2006-05-10
    • Jeffery D. SnellJong GillGene A. BornzinPeter BoileauEuljoon Park
    • Jeffery D. SnellJong GillGene A. BornzinPeter BoileauEuljoon Park
    • A61B5/04
    • A61B5/0402A61B5/0006A61N1/3702A61N1/37235A61N1/37282
    • A surface electrocardiogram (EKG) is emulated using signals detected by internal leads of an implanted device. In one example, emulation is performed using a technique that concatenates portions of signals sensed using different electrodes, such as by combining far-field ventricular signals sensed in the atria with far-field atrial signals sensed in the ventricles. In another example, emulation is performed using a technique that selectively amplifies or attenuates portions of a single signal, such as by attenuating near-field portions of an atrial unipolar signal relative to far-field portions of the same signal. The surface EKG emulation may be performed by the implanted device itself or by an external programmer based on cardiac signals transmitted thereto. A transtelephonic monitoring network is also described, wherein the emulated surface EKG (or raw data used to emulate the EKG) is relayed from an implanted device to a remote monitor, typically installed in a physician's office.
    • 使用由植入装置的内部引线检测的信号来模拟表面心电图(EKG)。 在一个示例中,使用将使用不同电极感测的信号的部分连接的技术来执行仿真,例如通过将在心房中感测到的远场心室信号与在心室中感测到的远场心房信号组合。 在另一示例中,使用选择性地放大或衰减单个信号的部分的技术来执行仿真,例如通过衰减相对于相同信号的远场部分的心房单极信号的近场部分。 表面EKG仿真可以由植入装置本身或外部编程器基于发送到其上的心脏信号执行。 还描述了一种跨耳监测网络,其中仿真表面EKG(或用于模拟EKG的原始数据)从植入装置中继到通常安装在医师办公室中的远程监视器。
    • 55. 发明授权
    • Apnea burden minimizing cardiac stimulation device
    • 呼吸暂停负担最小化心脏刺激装置
    • US07725181B1
    • 2010-05-25
    • US11291310
    • 2005-11-30
    • Gene A. BornzinEuljoon Park
    • Gene A. BornzinEuljoon Park
    • A61N1/00
    • A61N1/368A61B5/113A61B5/4818A61N1/36514A61N1/3682
    • An implantable cardiac device minimizes apnea burden. In one implementation, the device administers a series of cardiac pacing trials using a different value for a pacing parameter in each trial and then measures an apnea burden corresponding to each trial in order to determine a value which reduces apnea burden when used for ongoing cardiac pacing. In one implementation the implantable cardiac device performs series of trials in cycles, during which a first series of trials determines a value for a first pacing parameter for reducing apnea burden while other pacing parameters are held constant. Subsequent series of trials subject the other pacing parameters, in turn, to their own series of pacing trials while holding the non-subjected pacing parameters constant. Through multiple cycles, the device optimizes each parameter in turn based on continually improving values for the other pacing parameters.
    • 可植入的心脏装置使呼吸暂停负担最小化。 在一个实施方案中,该装置使用每个试验中的起搏参数使用不同的值进行一系列心脏起搏试验,然后测量与每次试验相对应的呼吸暂停负担,以便确定当用于持续心脏起搏时减少呼吸暂停负担的值 。 在一个实施方案中,可植入心脏装置以周期执行一系列试验,在此期间,第一系列试验确定第一起搏参数的值以减少呼吸暂停负担,而其他起搏参数保持恒定。 随后的一系列试验将其他起搏参数反过来归因于其自己的一系列起搏试验,同时保持不受起搏的起搏参数不变。 通过多个循环,设备会根据其他起搏参数的持续改进值轮流优化每个参数。
    • 58. 发明授权
    • System and method for predicting a heart condition based on impedance values using an implantable medical device
    • 基于使用可植入医疗装置的阻抗值来预测心脏病的系统和方法
    • US07272443B2
    • 2007-09-18
    • US11014276
    • 2004-12-15
    • Xiaoyi MinGene A. BornzinEuljoon Park
    • Xiaoyi MinGene A. BornzinEuljoon Park
    • A61N1/365
    • A61N1/36521A61B5/0538A61N1/3627A61N1/371
    • Techniques are provided for predicting the onset of a heart condition within a patient based on impedance measurements. Briefly, overloads in fluid levels in the thorax and in ventricular myocardial mass within the patient are detected based on impedance signals sensed using implanted electrodes. The onset of certain heart conditions is then predicted based on the overloads. For example, pulmonary edema arising due to diastolic heart failure is predicted based on the detection of on-going overloads in both fluid levels and ventricular mass. Ventricular hypertrophy is detected based on an on-going ventricular mass overload without a sustained fluid overload. Various other heart conditions may also be predicted based on specific combinations of recent or on-going overloads. Evoked response is exploited to corroborate the predictions. Appropriate warning signals are generated and preemptive therapy is initiated.
    • 提供了基于阻抗测量来预测患者心脏病状发作的技术。 简单地说,基于使用植入电极感测到的阻抗信号来检测患者胸部液位水平和心室心肌质量的过载。 然后基于过载来预测某些心脏状况的发作。 例如,由于舒张性心力衰竭引起的肺水肿基于检测流体水平和心室质量中的持续过载而被预测。 基于正在进行的心室质量超载而无持续的流体超载检测出心室肥大。 还可以基于最近或正在进行的过载的特定组合来预测各种其他心脏状况。 被诱发的反应被利用来证实预测。 产生适当的警告信号并开始抢先治疗。